AstraZeneca buys US biotech firm CinCor / Photo: Jonathan NACKSTRAND - AFP/File
-
Oversight Board blasts 'inadequate' Meta safeguards for AI deepfakes
-
Hispanics feel 'betrayed' on immigration, Republican warns Trump
-
The Easter Island origins of buzzy Malkovich drama 'Wild Horse Nine'
-
High-scoring Bears face Vikings in battle of NFL unbeatens
-
Third body recovered after Grand Canyon flash flood
-
'In our lane': Fed's Warsh defies Trump but still fighting for credibility
-
Harry makes first public appearance since return to UK
-
Trump admin makes major cut to endangered species protections
-
Abhishek hits record T20 ton as India sweep series 3-0
-
Princess Diana's brother makes new explosive claims against Charles
-
Abhishek hits record T20 ton as India sweep T20 series 3-0
-
Ovechkin on Russian political video: 'I support my country'
-
English FA calls for Infantino to release World Cup sell-off documents
-
Can we shut down AI?
-
GM delivers first components for US interceptor missiles
-
Teenager Sullivan named in new-look US squad
-
Trump admin overhauls key protection for endangered species
-
Travis Scott and Keith Richards feature on GTA VI soundtrack
-
Abhishek hits record T20 ton as India post 221-7 against Afghanistan
-
AFP photo shows Trump examining image of apparent Kennedy Center razing
-
Macron hosts Lebanon security talks to back 'indispensable' army
-
Pochettino rings changes for USA friendlies
-
Final rally of season in Saudi Arabia cancelled due to Middle East conflict
-
Alonso says Chelsea ambition 'very clear' after end of Boehly era
-
Gaza documentary sparks political storm in Israel
-
Mbappe draws political fire over Ceuta t-shirt controversy
-
King Charles warns tech bosses of 'existential dangers' of AI
-
Third malaria death in Germany from outbreak tied to Frankfurt airport
-
French fishermen block ports over petrol prices
-
AtlasClear Holdings Reports Preliminary Fiscal 2026 Revenue of Approximately $20.1 Million, Up 85%; Revenue Plus Interest Income of Approximately $21.9 Million
-
AFP photo shows Trump examining image of Kennedy Center apparent demolition
-
Alonso says Chelsea ambition clear after end of Boehly era
-
Andersson vows to take Sweden in 'new direction' after election win
-
Micron's Taiwan workers say 68 months' bonus not enough
-
Turkey's Erdogan to run again in early 2028 vote, top adviser says
-
'Another arrow to the quiver': World Bank posts record private capital mobilization
-
Sweden's Andersson: a trusted, no-nonsense political operator
-
Macron hosts Lebanon security talks as UN mission nears end
-
Canada's Carney pushes 'new alliance' with EU despite Trump threats
-
From land to race laws: what's driving the US-South Africa rift?
-
Ireland to boycott Eurovision 2027 over Gaza
-
Beyond Investment Returns: Families Are Measuring Wealth by Freedom, Continuity, and Legacy, According to Nour Private Wealth
-
India's Tata Sons reappoints N. Chandrasekaran as chairman
-
King Charles disputes claims in book by Princess Diana's brother
-
Sweden's left-wing wins election thriller
-
Real Madrid fan group wants Mbappe apology over Ceuta shirt snub
-
Germany urges EU action against China to defend carmakers
-
Nepal floods among 'most challenging' disasters: WFP
-
Stocks mostly rise after US Fed rate hike, oil eases
-
Doubts as Italy eyes electric future for steel plant
AstraZeneca buys US biotech firm CinCor
Anglo-Swedish pharmaceuticals giant AstraZeneca on Monday agreed to buy US biotech company CinCor for $1.8 billion, expanding further into the field of heart and kidney drugs.
The takeover marks the latest push by Astra chief executive Pascal Soriot to bolster the Covid vaccine maker's pipeline of new products.
Massachusetts-based CinCor focuses on developing treatments for hypertension and chronic kidney disease.
Since taking the helm at AstraZeneca in 2012, Frenchman Soriot has expanded the company into lucrative cancer therapies.
The group completed a blockbuster takeover of Alexion for $39 billion in 2021, giving it more heft in areas such as treating blood disorders.
A.Ruiz--AT